Viewing Study NCT00397293


Ignite Creation Date: 2025-12-25 @ 1:19 AM
Ignite Modification Date: 2025-12-25 @ 11:28 PM
Study NCT ID: NCT00397293
Status: COMPLETED
Last Update Posted: 2010-08-24
First Post: 2006-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Sponsor: Ascenta Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module